Patients needing costly biologic drugs for autoimmune and chronic conditions often face insurance denials that delay or block treatment. With strong medical documentation, standardized appeal ...

Pregnant women who take biologic medication for rheumatoid arthritis are not running the risk of their infant developing serious/opportunistic infections, according to research presented at the 2017 ...

Last year, 43% of U.S. adults did not take their medication as prescribed because of the cost of prescription drugs. These rising drug prices hit American seniors, small businesses, and middle-class ...

Posters presented at the American Academy of Dermatology Annual Meeting identified significant undertreatment of psoriasis and significant gaps in biologic medication treatment. This content was ...

The Biologic Therapeutic Drug Market has emerged as one of the most transformative segments within the global healthcare industry, driven by advancements in biotechnology and increasing demand for ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, is employing an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines to ...

The FDA recently designated Yuflyma as "interchangeable" with the popular biologic Humira for the treatment of Crohn's disease and ulcerative colitis, two types of inflammatory bowel disease (IBD), ...

Biologic drugs have improved how doctors treat serious illnesses. Instead of being made from chemicals, biologics are made from organic materials and grown in living cells. Biologic drugs are used ...

Halozyme (HALO) is evolving from an ENHANZE royalty story into a diversified subcutaneous drug delivery platform, expanding ...

Seul Eunjin, AGC Biologics; Kunii Shigeru, AGC Biologics; Sung Gong, Novelty Nobility; Park Chan-Hee, Novelty Nobility; ...

However, maintaining the stability of liquid biological products can be challenging. Many protein types, including monoclonal antibodies, multispecific antibodies, antibody fragments, fusion proteins, ...

New legislation would authorize pharmacists to substitute a biosimilar when filling a prescription, just like a generic, provided your doctor agrees.